JP Morgan Chase
ZURA icon

JP Morgan Chase’s Zura Bio ZURA Stock Holding History

JP Morgan Chase’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.5M Sell
4,354,715
-104,136
-2% -$496K ﹤0.01% 2045
2026
Q1 		$25.3M Sell
4,458,851
-13,905
-0.3% -$84K ﹤0.01% 1890
2025
Q4 		$23.4M Sell
4,472,756
-151,443
-3% -$599K ﹤0.01% 1929
2025
Q3 		$20M Sell
4,624,199
-35,752
-0.8% -$64.3K ﹤0.01% 2101
2025
Q2 		$4.89M Buy
4,659,951
+2,052,732
+79% +$2.45M ﹤0.01% 3193
2025
Q1 		$3.36M Sell
2,607,219
-25,966
-1% -$41K ﹤0.01% 3488
2024
Q4 		$6.58M Buy
2,633,185
+2,611,532
+12,061% +$9.3M ﹤0.01% 3099
2024
Q3 		$87.9K Sell
21,653
-3,151
-13% -$11.8K ﹤0.01% 5754
2024
Q2 		$86.8K Buy
24,804
+17,520
+241% +$71.4K ﹤0.01% 5601
2024
Q1 		$18.7K Sell
7,284
-4,946
-40% -$17.5K ﹤0.01% 6241
2023
Q4 		$57.1K Buy
12,230
+4,411
+56% +$22.1K ﹤0.01% 5958
2023
Q3 		$51.6K Buy
7,819
+1,776
+29% +$11.9K ﹤0.01% 5799
2023
Q2 		$49.6K Buy
+6,043
New +$48.5K ﹤0.01% 5725

Other funds holding ZURA

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return

JP Morgan Chase's ZURA Position: Q2 2026 in Review

JP Morgan Chase reduced its Zura Bio (ZURA) stake by 2.3% in Q2 2026, selling an estimated $496K and leaving 4,354,715 shares worth $24.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2045.

JP Morgan Chase first reported a position in ZURA in Q2 2023 and has held it in 13 quarters since. The position peaked at $25.3M in Q1 2026. 95 funds tracked by Wall St. Rank hold ZURA as of Q2 2026.

  • JP Morgan Chase held 4,354,715 shares of Zura Bio worth $24.5M as of Q2 2026.
  • JP Morgan Chase sold 104,136 Zura Bio shares in Q2 2026, an estimated $496K.
  • Zura Bio made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #2045 holding.
  • JP Morgan Chase first reported a position in Zura Bio in Q2 2023 and has held it in 13 quarters since.
  • JP Morgan Chase's Zura Bio position peaked at $25.3M in Q1 2026.
  • 95 funds tracked by Wall St. Rank held Zura Bio as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.